These results suggest that SRSF10 could play a previously uncharacterized role in controlling mRNA polyadenylation in the liver, and decreased SRSF10 expression could lead to dysregulated mRNA polyadenylation in NAFLD. The gene discussed is SRSF10; the disease is metabolic dysfunction-associated steatotic liver disease.